Sam Brusco, Associate Editor02.10.22
Vertebral implant maker Implanet has completed the first surgeries in the U.S. using its latest technology from the JAZZ range—JAZZ PF.
Using JAZZ PF, surgeons can create a soft landing of posterior spinal constructs to prevent proximal junctional kyphosis (PJK), a relatively common and serious complication after adult spinal deformity surgery.
JAZZ PF creates a stiffness gradient between upper instrumented vertebrae and the tethered proximal segmental level. The technology has both a CE mark and U.S. Food and Drug Administration (FDA) 510(k) clearance. JAZZ PF requires no specific instrumentation, as well.
“I have been using Implanet’s Jazz Band for some time, with excellent results in complex adult spinal deformity indications,” lliam Barrick, M.D. of Orthopedic Associates of Dutchess County told the press. “The addition of JAZZ PF to Implanet’s range is a major breakthrough in the protection of the adjacent level. This new implant has been easy to use during the first surgical procedures and has supplied encouraging early post-operative clinical results. We will monitor these patients to confirm these results over the longer term. I believe that JAZZ PF will rapidly become an essential tool for spine surgeons.”
Ludovic Lastennet, CEO of Implanet, added: “JAZZ PF provides a response both to the issues surgeons face in degenerative disorders and more importantly to the budgetary requirements placed on American healthcare facilities during this post-pandemic period. This new implant was launched in Europe last September, and the marketing of this unique solution on the US market by our Implanet America team began during the final quarter of 2021. This concept has rapidly generated considerable interest from spine surgeons specializing in the treatment of large deformities in adults, the first step in positioning ourselves in this large-scale market estimated at 37,000 surgical procedures and to be worth $348 million a year. For the first time, we have a universal solution that can be used in 25 to 30 percent of procedures.”
Using JAZZ PF, surgeons can create a soft landing of posterior spinal constructs to prevent proximal junctional kyphosis (PJK), a relatively common and serious complication after adult spinal deformity surgery.
JAZZ PF creates a stiffness gradient between upper instrumented vertebrae and the tethered proximal segmental level. The technology has both a CE mark and U.S. Food and Drug Administration (FDA) 510(k) clearance. JAZZ PF requires no specific instrumentation, as well.
“I have been using Implanet’s Jazz Band for some time, with excellent results in complex adult spinal deformity indications,” lliam Barrick, M.D. of Orthopedic Associates of Dutchess County told the press. “The addition of JAZZ PF to Implanet’s range is a major breakthrough in the protection of the adjacent level. This new implant has been easy to use during the first surgical procedures and has supplied encouraging early post-operative clinical results. We will monitor these patients to confirm these results over the longer term. I believe that JAZZ PF will rapidly become an essential tool for spine surgeons.”
Ludovic Lastennet, CEO of Implanet, added: “JAZZ PF provides a response both to the issues surgeons face in degenerative disorders and more importantly to the budgetary requirements placed on American healthcare facilities during this post-pandemic period. This new implant was launched in Europe last September, and the marketing of this unique solution on the US market by our Implanet America team began during the final quarter of 2021. This concept has rapidly generated considerable interest from spine surgeons specializing in the treatment of large deformities in adults, the first step in positioning ourselves in this large-scale market estimated at 37,000 surgical procedures and to be worth $348 million a year. For the first time, we have a universal solution that can be used in 25 to 30 percent of procedures.”